Health markets in Africa are shaped less by consumer demand than by government procurement, donor funding and regulatory approval pathways. A product with a strong clinical and commercial case can still struggle if it is misaligned with how a ministry procures, or how a donor programme structures its funding cycle.
Health and health systems
This is one of the sectors where political economy and market assessment are hardest to separate. Who controls procurement decisions, how donor priorities shift, and where private provision is tolerated or restricted often decide whether an investment succeeds.
How we approach it
We map procurement processes and donor funding structures alongside the political relationships that influence them, combining our political economy analysis and market entry advisory services to give a fuller picture than a market study alone would provide.
What clients gain
A realistic view of whether a health investment's commercial logic can clear the procurement and policy environment it depends on, before capital is committed.
Who we usually advise here
Investors assessing opportunities in private healthcare and health technology. Corporates navigating procurement and regulatory approval. Development finance institutions and foundations structuring programmes that need to work within public health system constraints.